GSK records 2% rise for Consumer Healthcare

2 May 2017 - Deborah Wilkes

Archived

A late start to the allergy season and weakness in international markets curbed growth at GlaxoSmithKline's Consumer Healthcare division in the first quarter of 2017. Worldwide sales at the division increased by 2% at constant exchange rates to GBP2.04 billion (USD2.62 billion) in the three months.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: